HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The signalling pathway of CaMKII-mediated apoptosis and necrosis in the ischemia/reperfusion injury.

Abstract
Ca(2+)-calmodulin-dependent protein kinase II (CaMKII) plays an important role mediating apoptosis/necrosis during ischemia-reperfusion (IR). We explored the mechanisms of this deleterious effect. Langendorff perfused rat and transgenic mice hearts with CaMKII inhibition targeted to sarcoplasmic reticulum (SR-AIP) were subjected to global IR. The onset of reperfusion increased the phosphorylation of Thr(17) site of phospholamban, without changes in total protein, consistent with an increase in CaMKII activity. Instead, there was a proportional decrease in the phosphorylation of Ser2815 site of ryanodine receptors (RyR2) and the amount of RyR2 at the onset of reperfusion, i.e. the ratio Ser2815/RyR2 did not change. Inhibition of the reverse Na(+)/Ca(2+)exchanger (NCX) mode (KBR7943) diminished phospholamban phosphorylation, reduced apoptosis/necrosis and enhanced mechanical recovery. CaMKII-inhibition (KN-93), significantly decreased phospholamban phosphorylation, infarct area, lactate dehydrogenase release (LDH) (necrosis), TUNEL positive nuclei, caspase-3 activity, Bax/Bcl-2 ratio and Ca(2+)-induced mitochondrial swelling (apoptosis), and increased contractile recovery when compared with non-treated IR hearts or IR hearts pretreated with the inactive analog, KN-92. Blocking SR Ca(2+) loading and release (thapsigargin/dantrolene), mitochondrial Ca(2+) uniporter (ruthenium red/RU360), or mitochondrial permeability transition pore (cyclosporine A), significantly decreased infarct size, LDH release and apoptosis. SR-AIP hearts failed to show an increase in the phosphorylation of Thr(17) of phospholamban at the onset of reflow and exhibited a significant decrease in infarct size, apoptosis and necrosis respect to controls. The results reveal an apoptotic-necrotic pathway mediated by CaMKII-dependent phosphorylations at the SR, which involves the reverse NCX mode and the mitochondria as trigger and end effectors, respectively, of the cascade.
AuthorsMargarita A Salas, Carlos A Valverde, Gina Sánchez, Matilde Said, Jesica S Rodriguez, Enrique L Portiansky, Marcia A Kaetzel, John R Dedman, Paulina Donoso, Evangelia G Kranias, Alicia Mattiazzi
JournalJournal of molecular and cellular cardiology (J Mol Cell Cardiol) Vol. 48 Issue 6 Pg. 1298-306 (Jun 2010) ISSN: 1095-8584 [Electronic] England
PMID20060004 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright(c) 2009 Elsevier Ltd. All rights reserved.
Chemical References
  • Electron Transport Complex IV
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Camk2a protein, mouse
  • Camk2a protein, rat
  • Caspase 3
Topics
  • Animals
  • Apoptosis
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 (metabolism)
  • Caspase 3 (metabolism)
  • Electron Transport Complex IV (metabolism)
  • Male
  • Mice
  • Mice, Transgenic
  • Mitochondria (metabolism)
  • Models, Biological
  • Necrosis
  • Phosphorylation
  • Rats
  • Rats, Wistar
  • Reperfusion Injury (metabolism)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: